The COVID-19 pandemic has been one of the greatest public health challenges imposing
significant economic and societal costs. A wide range of public health interventions (PHIs) …

Objectives The COVID-19 pandemic has had a major impact on our society, with drastic
policy restrictions being implemented to contain the spread of the severe acute respiratory …

Background We aimed to quantitatively summarise the health economic evaluation
evidence of prevention and control programs addressing COVID-19 globally. Methods We …

Background Without any pharmaceutical intervention and vaccination, the only way to
combat Coronavirus Disease 2019 (COVID-19) is to slow down the spread of the disease by …

Background The COVID-19 outbreak was defined as a pandemic on 11 March 2020 by the
World Health Organization. After that, COVID-19 has enormously influenced health systems …

Estimates of the global economic costs of coronavirus disease 2019 (COVID-19) vary from
$77 billion to as high as $2.7 trillion. 1 As of this writing, there have been over 4.3 million …

Background Countries vary in their response to the COVID-19 pandemic. Some emphasise
social distancing, while others focus on other interventions. Evidence on the effectiveness …

Objectives The economic burden of COVID-19 pandemic is substantial, with both direct and
indirect costs playing a significant role. Design A systematic literature review was conducted …

Objective To review published economic evaluations of antiviral treatment for pandemics
and outbreaks of respiratory illnesses. Methods We conducted a systematic review to …

Non-Pharmaceutical Public Health Interventions (NPHIs) have been used by different
countries to control the spread of the COVID-19. Despite available evidence regarding the …